Approval · Notice of Compliance 2289 · 2001
COPAXONE: Notice of Compliance 2289
Issued September 21, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2289
- Date
- September 21, 2001
- Company
- Teva Pharmaceuticals Usa
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To provide for additional wording under clinical studies to include results from a mri-monitored study
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | Not yet assigned | — |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per VIAL